Search Results - "Paquet, Charlotte"
-
1
Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent in vivo MET receptor agonist
Published in Chemical science (Cambridge) (01-03-2015)“…The development of MET receptor agonists is an important goal in regenerative medicine, but is limited by the complexity and incomplete understanding of its…”
Get full text
Journal Article -
2
Bone marrow p16INK4a-deficiency does not modulate obesity, glucose homeostasis or atherosclerosis development
Published in PloS one (05-03-2012)“…A genomic region near the CDKN2A locus, encoding p16(INK4a), has been associated to type 2 diabetes and atherosclerotic vascular disease, conditions in which…”
Get full text
Journal Article -
3
p16INK4a deficiency promotes IL-4–induced polarization and inhibits proinflammatory signaling in macrophages
Published in Blood (01-09-2011)“…The CDKN2A locus, which contains the tumor suppressor gene p16INK4a, is associated with an increased risk of age-related inflammatory diseases, such as…”
Get full text
Journal Article -
4
The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis
Published in Atherosclerosis (01-06-2016)“…Abstract Background Atherosclerosis is characterized by lipid accumulation and chronic inflammation in the arterial wall. Elevated levels of apolipoprotein…”
Get full text
Journal Article -
5
Rev-erb-α modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy
Published in Nature medicine (01-08-2013)“…Bart Staels and his colleagues show that the transcription factor Rev-erb-α is highly expressed in oxidative muscle and, via loss- and gain-of-function…”
Get full text
Journal Article -
6
Hypoxia leads to decreased autophosphorylation of the MET receptor but promotes its resistance to tyrosine kinase inhibitors
Published in Oncotarget (05-06-2018)“…The receptor tyrosine kinase MET and its ligand, the Hepatocyte Growth Factor/Scattor Factor (HGF/SF), are essential to the migration, morphogenesis, and…”
Get full text
Journal Article -
7
Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice
Published in Nature communications (02-12-2016)Get full text
Journal Article -
8
Abstract 19434: The Novel PPARalpha-Selective Agonist K-877 Improves Dyslipidemia, Enhances Reverse Cholesterol Transport and Decreases Inflammation and Atherosclerosis
Published in Circulation (New York, N.Y.) (26-11-2013)“…Abstract only Background: Atherosclerosis is characterized by lipid accumulation and chronic inflammation in the arterial wall. Elevated levels of…”
Get full text
Journal Article -
9
Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent in vivo MET receptor agonistElectronic supplementary information (ESI) available: Descriptions of reagents, antibodies, immunoblotting, MTT assay, scattering assay, morphogenesis assay and statistical analysis. See DOI: 10.1039/c4sc03856h
Published 16-02-2015“…The development of MET receptor agonists is an important goal in regenerative medicine, but is limited by the complexity and incomplete understanding of its…”
Get full text
Journal Article -
10
Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent in vivo MET receptor agonist† †Electronic supplementary information (ESI) available: Descriptions of reagents, antibodies, immunoblotting, MTT assay, scattering assay, morphogenesis assay and statistical analysis. See DOI: 10.1039/c4sc03856h Click here for additional data file
Published in Chemical science (Cambridge) (29-01-2015)“…Clustering of synthetic biotinylated K1 domain from HGF/SF by streptavidin is sufficient to generate a potent MET agonist. The development of MET receptor…”
Get full text
Journal Article -
11
Rev-erb-[alpha] modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy
Published in Nature medicine (01-08-2013)“…The nuclear receptor Rev-erb-α modulates hepatic lipid and glucose metabolism, adipogenesis and the inflammatory response in macrophages. We show here that…”
Get full text
Journal Article -
12
Bone Marrow p16.sup.INK4a-Deficiency Does Not Modulate Obesity, Glucose Homeostasis or Atherosclerosis Development
Published in PloS one (05-03-2012)“…Objective A genomic region near the CDKN2A locus, encoding p16.sup.INK4a, has been associated to type 2 diabetes and atherosclerotic vascular disease,…”
Get full text
Journal Article -
13
p16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages: p16INK4a function in macrophages
Published in Blood (01-09-2011)“…The CDKN2A locus, which contains the tumor suppressor gene p16(INK4a), is associated with an increased risk of age-related inflammatory diseases, such as…”
Get full text
Journal Article